Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vivimed Labs Ltd. Board/Management Information 2026

Feb 2, 2026

61575_rns_2026-02-02_8c6109eb-1da3-48f5-a9b3-33e2973a7541.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

Date: 02.02.2026

To BSE - Code : 532660 Mumbai - 400 051

BSE Limited * National Stock Exchange of India Ltd. P.J. Towers, Dalal Street, Exchange Plaza,Plot no. C/1, G Block, Mumbai — 400001 Bandra-Kurla Complex, Bandra (E) NSE- Symbol: VIVIMEDLAB

Dear Sir/Madam,

Sub: Notice of Board Meeting -reg.

Pursuant to Regulation 29 of SEBI (Listing Obligations & Disclosure Requirements), 2015 we hereby bring to your notice that the meeting of the Board of Directors of the Company is scheduled to be held on Friday, 13" Day of February, 2026 at Hyderabad inter alia to consider and approve un-audited Financial Results (Standalone & Consolidated) of the company for the quarter and Nine Months ending 31%' December, 2025 & any other items.

Kindly take the above information on records.

Yours faithfully, For VIVIMED LABS LIMITED

Crpg

YUGANDHAR KOPPARTHI COMPANY SECRETARY

Vivimed Labs Limited. Corporate Office: CIN : L02411KA1988PLC0O09455 6-3-866/1/G1, 3rd Floor, GMR Towers, Registered Office: #78/A, Kolhar Industrial Area, Greelands, Begumpet, Hyderabad Bidar, Kamataka-585 403, India Telengana-500 016, India. T+91(0) 8482-232045, F+91 (0 8482-232436 GSTIN: 36AAACV6060A12Q Email: [email protected] | www.vivimedlabs.com T 91(0) 40-6608-6608, F+91(0) 40-6608-6699